Angiotensin II Type 1 Receptor Blocker Telmisartan Reduces Cerebral Infarct Volume and Peri-infarct Cytosolic Phospholipase A2 Level in Experimental Stroke
Author:
Affiliation:
1. Department of Neurosurgery, Tokyo Women's Medical University, Tokyo, Japan.
2. Department of Pathology, Tokyo Women's Medical University, Tokyo, Japan.
Publisher
Mary Ann Liebert Inc
Subject
Clinical Neurology
Link
http://www.liebertpub.com/doi/pdf/10.1089/neu.2009.0965
Reference38 articles.
1. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia
2. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.
3. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.
4. Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating Activity
5. PPAR-γ Agonists as Regulators of Microglial Activation and Brain Inflammation
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The angiotensin II receptors type 1 and 2 modulate astrocytes and their crosstalk with microglia and neurons in an in vitro model of ischemic stroke;BMC Neuroscience;2024-06-26
2. Eprosartan: A closer insight into its neuroprotective activity in rats with focal cerebral ischemia–reperfusion injury;Journal of Biochemical and Molecular Toxicology;2021-05-03
3. The Role of Sartans in the Treatment of Stroke and Subarachnoid Hemorrhage: A Narrative Review of Preclinical and Clinical Studies;Brain Sciences;2020-03-07
4. Modulation of brain ACE and ACE2 may be a promising protective strategy against cerebral ischemia/reperfusion injury: an experimental trial in rats;Naunyn-Schmiedeberg's Archives of Pharmacology;2018-06-17
5. Telmisartan Activates PPARδ to Improve Symptoms of Unpredictable Chronic Mild Stress-Induced Depression in Mice;Scientific Reports;2017-10-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3